<?xml version="1.0" encoding="UTF-8" standalone="no"?><document setID="333ee96f-66b6-415f-9ea3-0710b3eee1dd"><labelDrug name="Uniretic"><Normalization><mmtx cui="C0724120" preferredWord="Uniretic" semType="phsu, orch"/></Normalization></labelDrug><generic name="moexipril hydrochloride and hydrochlorothiazide"/><sentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.1" text="UNIRETIC (moexipril hydrochloride and hydrochlorothiazide) tablet, film coated" type="negative"><entity charOffset="10:33" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.1.e.0" text="moexipril hydrochloride" type="Biomedical_Entity"><Normalization><mmtx cui="C0771294" phraseText="(moexipril hydrochloride" preferredWord="Moexipril hydrochloride" semType="phsu, orch"/><RxNorm RxCui="236066"/></Normalization></entity><entity charOffset="38:57" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.1.e.1" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="0:8" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.1.e.2" text="uniretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0724120" phraseText="UNIRETIC" preferredWord="Uniretic" semType="phsu, orch"/><RxNorm RxCui="220670"/></Normalization></entity><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.1.e.0" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.1.e.1"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.1.e.2" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.1.e.0"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.1.e.2" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.1.e.1"/></sentence><sentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.3" text="uniretic (moexipril hydrochloride/hydrochlorothiazide) is a combination of an angiotensin-converting enzyme (ACE) inhibitor, moexipril hydrochloride, and a diuretic, hydrochlorothiazide." type="negative"><entity charOffset="166:185" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.3.e.0" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="a diuretic, hydrochlorothiazide." preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="0:8" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.3.e.1" text="uniretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0724120" phraseText="uniretic" preferredWord="Uniretic" semType="phsu, orch"/><RxNorm RxCui="220670"/></Normalization></entity><entity charOffset="10:53" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.3.e.2" text="moexipril hydrochloride/hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0717828" phraseText="(moexipril hydrochloride/hydrochlorothiazide" preferredWord="Hydrochlorothiazide / moexipril" semType="phsu, orch"/><RxNorm RxCui="236066"/></Normalization></entity><entity charOffset="78:123" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.3.e.3" text="angiotensin-converting enzyme inhibitor" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="a combination of an angiotensin-converting enzyme (ACE) inhibitor," preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="6162"/></Normalization></entity><entity charOffset="156:164" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.3.e.4" text="diuretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="a diuretic, hydrochlorothiazide." preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="125:148" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.3.e.5" text="moexipril hydrochloride" type="Biomedical_Entity"><Normalization><mmtx cui="C0771294" phraseText="moexipril hydrochloride," preferredWord="Moexipril hydrochloride" semType="phsu, orch"/><RxNorm RxCui="236066"/></Normalization></entity><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.3.e.1" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.3.e.0"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.3.e.2" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.3.e.0"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.3.e.3" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.3.e.0"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.3.e.4" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.3.e.0"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.3.e.5" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.3.e.0"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.3.e.1" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.3.e.2"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.3.e.1" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.3.e.3"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.3.e.1" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.3.e.4"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.3.e.1" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.3.e.5"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.3.e.2" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.3.e.3"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.3.e.2" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.3.e.4"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.3.e.2" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.3.e.5"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.3.e.3" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.3.e.4"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.3.e.3" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.3.e.5"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.3.e.5" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.3.e.4"/></sentence><sentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.10" text="uniretic is contraindicated in patients who are hypersensitive to any component of this product and in patients with a history of angioedema related to previous treatment with an ACE inhibitor. " type="negative"><entity charOffset="179:192" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.10.e.0" text="ace inhibitor" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="with an ACE inhibitor." preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="0:8" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.10.e.1" text="uniretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0724120" phraseText="uniretic" preferredWord="Uniretic" semType="phsu, orch"/><RxNorm RxCui="220670"/></Normalization></entity><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.10.e.1" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.10.e.0"/></sentence><sentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.11" text="Because of the hydrochlorothiazide component, this product is contraindicated in patients with anuria or hypersensitivity to other sulfonamide-derived drugs. " type="negative"><entity charOffset="131:142" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.11.e.0" text="sulfonamide" type="Biomedical_Entity"><Normalization><mmtx cui="C0599503" phraseText="hypersensitivity to other sulfonamide-derived drugs." preferredWord="Sulfonamide Anti-Infective Agents" semType="orch, antb"/><RxNorm RxCui="1427600"/></Normalization></entity><entity charOffset="15:34" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.11.e.1" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="Because of the hydrochlorothiazide component," preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.11.e.1" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.11.e.0"/></sentence><sentence biomedicalEntities="2" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.13" lineNumber="18" text="Do not co-administer aliskiren with uniretic in patients with diabetes (see PRECATIONS, Drug Interactions)." type="regular"><entity charOffset="21:30" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.13.e.0" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="aliskiren with uniretic" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="36:44" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.13.e.1" text="uniretic" type="Drug"><Normalization><mmtx cui="C0724120" phraseText="aliskiren with uniretic" preferredWord="Uniretic" semType="phsu, orch"/><RxNorm RxCui="220670"/></Normalization></entity><entity charOffset="62:70" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.13.e.2" text="diabetes" type="SPAN"><Normalization><mmtx cui="C0011847" phraseText="with diabetes" preferredWord="Diabetes" semType="dsyn"/><mmtx cui="C0011849" phraseText="with diabetes" preferredWord="Diabetes Mellitus" semType="dsyn"/></Normalization></entity><entity charOffset="0:20" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.13.e.3" text="Do not co-administer" type="Caution_Interaction"/><drugInteraction id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.13.ddi.1"><interaction trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.13.e.3"><relations><relation type="hasContext"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.13.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.13.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.13.e.0"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.13.e.2" ddi="true" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.13.e.0" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.13.e.1" trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.13.e.3" type="Caution_Interaction"/></sentence><sentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.16" text="Presumably because angiotensin-converting enzyme inhibitors affect the metabolism of eicosanoids and polypeptides, including endogenous bradykinin, patients receiving ACE inhibitors, including uniretic, may be subject to a variety of adverse reactions, some of them serious." type="negative"><entity charOffset="193:201" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.16.e.0" text="uniretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0724120" phraseText="uniretic," preferredWord="Uniretic" semType="phsu, orch"/><RxNorm RxCui="220670"/></Normalization></entity><entity charOffset="167:181" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.16.e.1" text="ace inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="ACE inhibitors," preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="19:59" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.16.e.2" text="angiotensin-converting enzyme inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="angiotensin-converting enzyme inhibitors" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="6162"/></Normalization></entity><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.16.e.1" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.16.e.0"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.16.e.2" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.16.e.0"/></sentence><sentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.18" text="Angioedema involving the face, extremities, lips, tongue, glottis, and/or larynx has been reported in patients treated with ACE inhibitors, including moexipril. " type="negative"><entity charOffset="124:138" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.18.e.0" text="ace inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="treated with ACE inhibitors," preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="150:159" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.18.e.1" text="moexipril" type="Biomedical_Entity"><Normalization><mmtx cui="C0066685" phraseText="moexipril." preferredWord="moexipril" semType="phsu, orch"/><RxNorm RxCui="236066"/></Normalization></entity><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.18.e.0" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.18.e.1"/></sentence><sentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.31" text="The angioedema was diagnosed by procedures including abdominal CT scan or ultrasound, or at surgery, and symptoms resolved after stopping the ACE inhibitor. " type="negative"><entity charOffset="142:155" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.31.e.0" text="ace inhibitor" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="the ACE inhibitor." preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="129:137" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.31.e.1" text="stopping" type="Biomedical_Entity"><Normalization><mmtx cui="C0723457" phraseText="resolved after stopping" preferredWord="Stop brand of fluoride" semType="inch, phsu"/><RxNorm RxCui="220037"/></Normalization></entity><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.31.e.1" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.31.e.0"/></sentence><sentence biomedicalEntities="2" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.34" lineNumber="40" text="Two patients undergoing desensitizing treatment with hymenoptera venom while receiving ACE inhibitors sustained life-threatening anaphylactoid reactions. " type="regular"><entity charOffset="53:70" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.34.e.0" text="hymenoptera venom" type="Substance"><Normalization><mmtx cui="C1290000" phraseText="desensitizing treatment with hymenoptera venom" preferredWord="Hymenoptera venom" semType="phsu"/><RxNorm RxCui="390053"/></Normalization></entity><entity charOffset="87:101" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.34.e.1" text="ACE inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="receiving ACE inhibitors" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="0:12" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.34.e.2" text="Two patients" type="SPAN"/><entity charOffset="129:152" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.34.e.3" text="anaphylactoid reactions" type="Specific_Interaction"/><entity charOffset="112:128" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.34.e.5" text="life-threatening" type="SPAN"/><drugInteraction id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.34.ddi.1"><interaction trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.34.e.3"><relations><relation type="hasPrecipitant"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.34.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.34.e.1"/></relation><relation type="hasSeverity"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.34.e.5"/></relation><relation type="hasContext"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.34.e.2"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.34.e.2" ddi="true" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.34.e.0" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.34.e.1" severity="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.34.e.5" trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.34.e.3" type="Specific_Interaction"/></sentence><sentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.40" text="uniretic can cause symptomatic hypotension, although, as with other ACE inhibitors, this is unusual in uncomplicated hypertensive patients treated with uniretic alone. " type="negative"><entity charOffset="152:160" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.40.e.0" text="uniretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0724120" phraseText="treated with uniretic" preferredWord="Uniretic" semType="phsu, orch"/><RxNorm RxCui="220670"/></Normalization></entity><entity charOffset="0:8" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.40.e.1" text="uniretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0724120" phraseText="uniretic" preferredWord="Uniretic" semType="phsu, orch"/><RxNorm RxCui="220670"/></Normalization></entity><entity charOffset="68:82" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.40.e.2" text="ace inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="as with other ACE inhibitors," preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.40.e.2" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.40.e.0"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.40.e.1" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.40.e.2"/></sentence><sentence biomedicalEntities="3" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.43" lineNumber="50" text="The thiazide component of uniretic may potentiate the action of other antihypertensive drugs, especially ganglionic or peripheral adrenergic-blocking drugs. " type="irregular"><anaphoraRelation><antecedentSentence ID="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.21" Text="One patient treated with hydrochlorothiazide alone experienced laryngeal edema. "/><anaphoraEntity charOffset="4:34" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.43.e.3" text="thiazide component of uniretic" type="Expression"/><antecedentEntity charOffset="25:44" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.21.e.0" text="hydrochlorothiazide" type="Drug"/></anaphoraRelation><entity charOffset="70:92" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.43.e.0" text="antihypertensive drugs" type="Drug_Class"><Normalization><mmtx cui="C0003364" phraseText="the action of other antihypertensive drugs," preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><entity charOffset="119:155" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.43.e.1" text="peripheral adrenergic-blocking drugs" type="Drug_Class"><Normalization><mmtx cui="C0242889" phraseText="peripheral adrenergic-blocking drugs." preferredWord="Adrenergic Antagonists" semType="phsu"/><RxNorm RxCui="221187"/></Normalization></entity><entity charOffset="39:60" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.43.e.5" text="potentiate the action" type="Increase_Interaction"/><entity charOffset="105:115|130:155" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.43.e.7" text="ganglionic adrenergic-blocking drugs" type="Drug_Class"><Normalization><mmtx cui="C0242889" phraseText="peripheral adrenergic-blocking drugs." preferredWord="Adrenergic Antagonists" semType="phsu"/><RxNorm RxCui="1022042"/></Normalization></entity><classClassMembership drugClass="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.43.e.1"/><classClassMembership drugClass="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.43.e.7"/><drugInteraction id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.43.ddi.1"><interaction trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.43.e.5"><relations><relation type="hasObject"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.43.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.43.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.43.e.3" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.43.e.0" trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.43.e.5" type="Increase_Interaction"/></sentence><sentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.44" text="The antihypertensive effects of the thiazide component may also be enhanced in the postsympathectomy patient." type="negative"><entity charOffset="4:20" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.44.e.0" text="antihypertensive" type="Biomedical_Entity"><Normalization><mmtx cui="C0003364" phraseText="The antihypertensive effects of the thiazide component" preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><entity charOffset="36:44" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.44.e.1" text="thiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0541746" phraseText="The antihypertensive effects of the thiazide component" preferredWord="Thiazides" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.44.e.0" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.44.e.1"/></sentence><sentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.48" text="If hypotension occurs, the patient should be placed in a supine position and, if necessary, treated with an intravenous infusion of normal saline. uniretic treatment usually can be continued following restoration of blood pressure and volume." type="negative"><entity charOffset="132:145" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.48.e.0" text="normal saline" type="Biomedical_Entity"><Normalization><mmtx cui="C0445115" phraseText="treated with an intravenous infusion of normal saline. uniretic treatment usually" preferredWord="Normal saline" semType="inch, phsu"/><RxNorm RxCui="125464"/></Normalization></entity><entity charOffset="147:155" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.48.e.1" text="uniretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0724120" phraseText="treated with an intravenous infusion of normal saline. uniretic treatment usually" preferredWord="Uniretic" semType="phsu, orch"/><RxNorm RxCui="220670"/></Normalization></entity><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.48.e.0" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.48.e.1"/></sentence><sentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.52" text="As a consequence of inhibition of the renin-angiotensin-aldosterone system, changes in renal function may be anticipated in susceptible individuals. " type="negative"><entity charOffset="56:67" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.52.e.0" text="aldosterone" type="Biomedical_Entity"><Normalization><mmtx cui="C0002006" phraseText="of the renin-angiotensin-aldosterone system," preferredWord="Aldosterone" semType="strd, phsu, horm"/><RxNorm RxCui="1312358"/></Normalization></entity><entity charOffset="44:55" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.52.e.1" text="angiotensin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003018" phraseText="of the renin-angiotensin-aldosterone system," preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.52.e.1" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.52.e.0"/></sentence><sentence biomedicalEntities="2" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.54" lineNumber="62" text="Some hypertensive patients with no apparent preexisting renal vascular disease have developed increases in blood urea nitrogen and serum creatinine, usually minor and transient, especially when moexipril has been given concomitantly with a thiazide diuretic. " type="regular"><entity charOffset="194:203" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.54.e.0" text="moexipril" type="Drug"><Normalization><mmtx cui="C0066685" phraseText="moexipril" preferredWord="moexipril" semType="phsu, orch"/><RxNorm RxCui="236066"/></Normalization></entity><entity charOffset="240:257" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.54.e.1" text="thiazide diuretic" type="Drug_Class"><Normalization><mmtx cui="C0012802" phraseText="concomitantly with a thiazide diuretic." preferredWord="Thiazide Diuretics" semType="phsu, orch"/><mmtx cui="C3536861" phraseText="concomitantly with a thiazide diuretic." preferredWord="Thiazide Diuretic [EPC]" semType="phsu"/><RxNorm RxCui="141801"/></Normalization></entity><entity charOffset="5:78" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.54.e.2" text="hypertensive patients with no apparent preexisting renal vascular disease" type="SPAN"><Normalization><mmtx cui="C0268790" phraseText="Some hypertensive patients with no apparent preexisting renal vascular disease" preferredWord="Renal vascular disorder" semType="dsyn"/></Normalization></entity><entity charOffset="94:126" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.54.e.3" text="increases in blood urea nitrogen" type="Specific_Interaction"/><entity charOffset="94:106|131:147" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.54.e.5" text="increases in serum creatinine" type="Specific_Interaction"/><entity charOffset="94:147" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.54.e.7" text="increases in blood urea nitrogen and serum creatinine" type="SPAN"/><drugInteraction id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.54.ddi.1"><interaction trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.54.e.3"><relations><relation type="hasContext"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.54.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.54.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.54.e.0"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.54.ddi.2"><interaction trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.54.e.5"><relations><relation type="hasContext"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.54.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.54.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.54.e.0"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.54.e.2" ddi="true" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.54.e.0" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.54.e.1" trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.54.e.3" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="0" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.55" lineNumber="62" text="This is more likely to occur in patients with preexisting renal impairment. " type="irregular"><anaphoraRelation><antecedentSentence ID="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.54" Text="Some hypertensive patients with no apparent preexisting renal vascular disease have developed increases in blood urea nitrogen and serum creatinine, usually minor and transient, especially when moexipril has been given concomitantly with a thiazide diuretic. "/><anaphoraEntity charOffset="0:4" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.55.e.0" text="This" type="Expression"/><antecedentEntity charOffset="94:147" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.54.e.5" text="increases in serum creatinine" type="Specific_Interaction"/></anaphoraRelation><anaphoraRelation><antecedentSentence ID="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.54" Text="Some hypertensive patients with no apparent preexisting renal vascular disease have developed increases in blood urea nitrogen and serum creatinine, usually minor and transient, especially when moexipril has been given concomitantly with a thiazide diuretic. "/><anaphoraEntity charOffset="0:4" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.55.e.0" text="This" type="Expression"/><antecedentEntity charOffset="94:147" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.54.e.7" text="increases in blood urea nitrogen and serum creatinine" type="SPAN"/></anaphoraRelation><entity charOffset="0:4" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.55.e.2" text="This" type="Specific_Interaction"/><entity charOffset="58:74" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.55.e.4" text="renal impairment" type="SPAN"><Normalization><mmtx cui="C0035078" phraseText="with preexisting renal impairment." preferredWord="Kidney Failure" semType="dsyn"/><mmtx cui="C0341697" phraseText="with preexisting renal impairment." preferredWord="Renal impairment" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.55.ddi.1"><interaction trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.55.e.2"><relations><relation type="hasContext"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.55.e.4"/></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.54" text="Some hypertensive patients with no apparent preexisting renal vascular disease have developed increases in blood urea nitrogen and serum creatinine, usually minor and transient, especially when moexipril has been given concomitantly with a thiazide diuretic. "><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.54.e.1"/></ellipsisSentence></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.54" text="Some hypertensive patients with no apparent preexisting renal vascular disease have developed increases in blood urea nitrogen and serum creatinine, usually minor and transient, especially when moexipril has been given concomitantly with a thiazide diuretic. "><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.54.e.0"/></ellipsisSentence></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="1" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.56" lineNumber="62" text="There may be a need for dose adjustment of uniretic. " type="irregular"><entity charOffset="24:39" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.56.e.0" text="dose adjustment" type="Caution_Interaction"/><entity charOffset="43:51" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.56.e.2" text="uniretic" type="Drug"><Normalization><mmtx cui="C0724120" phraseText="a need for dose adjustment of uniretic." preferredWord="Uniretic" semType="phsu, orch"/><RxNorm RxCui="220670"/></Normalization></entity><drugInteraction id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.56.ddi.1"><interaction trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.56.e.0"><relations><relation type="hasObject"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.56.e.2"/></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.54" text="Some hypertensive patients with no apparent preexisting renal vascular disease have developed increases in blood urea nitrogen and serum creatinine, usually minor and transient, especially when moexipril has been given concomitantly with a thiazide diuretic. "><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.54.e.1"/></ellipsisSentence><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.55" text="This is more likely to occur in patients with preexisting renal impairment. "/></relation></relations></interaction></drugInteraction></sentence><sentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.58" text="In hypertensive patients with severe congestive heart failure, whose renal function may depend on the activity of the renin-angiotensin-aldosterone system, treatment with ACE inhibitors, including moexipril, may be associated with oliguria and/or progressive azotemia and, rarely, acute renal failure and/or death." type="negative"><entity charOffset="171:185" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.58.e.0" text="ace inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="treatment with ACE inhibitors," preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="136:147" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.58.e.1" text="aldosterone" type="Biomedical_Entity"><Normalization><mmtx cui="C0002006" phraseText="depend on the activity of the renin-angiotensin-aldosterone system," preferredWord="Aldosterone" semType="strd, phsu, horm"/><RxNorm RxCui="1312358"/></Normalization></entity><entity charOffset="197:206" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.58.e.2" text="moexipril" type="Biomedical_Entity"><Normalization><mmtx cui="C0066685" phraseText="moexipril," preferredWord="moexipril" semType="phsu, orch"/><RxNorm RxCui="236066"/></Normalization></entity><entity charOffset="124:135" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.58.e.3" text="angiotensin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003018" phraseText="depend on the activity of the renin-angiotensin-aldosterone system," preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.58.e.1" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.58.e.0"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.58.e.0" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.58.e.2"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.58.e.3" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.58.e.0"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.58.e.1" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.58.e.2"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.58.e.3" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.58.e.1"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.58.e.3" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.58.e.2"/></sentence><sentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.59" text="In hypertensive patients with unilateral or bilateral renal artery stenosis, increases in blood urea nitrogen and serum creatinine have been observed in some patients following ACE inhibitor therapy. " type="negative"><entity charOffset="96:100" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.59.e.0" text="urea" type="Biomedical_Entity"><Normalization><mmtx cui="C0041942" phraseText="increases in blood urea nitrogen" preferredWord="Urea" semType="bacs, phsu, orch"/><RxNorm RxCui="11002"/></Normalization></entity><entity charOffset="177:190" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.59.e.1" text="ace inhibitor" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="ACE inhibitor therapy." preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.59.e.0" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.59.e.1"/></sentence><sentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.60" text="These increases were almost always reversible upon discontinuation of the ACE inhibitor and/or diuretic therapy. " type="negative"><entity charOffset="95:103" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.60.e.0" text="diuretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="diuretic therapy." preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="74:87" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.60.e.1" text="ace inhibitor" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="almost always reversible upon discontinuation of the ACE inhibitor" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.60.e.1" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.60.e.0"/></sentence><sentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.63" text="Another ACE inhibitor, captopril, has been shown to cause agranulocytosis and bone marrow depression, rarely in patients with uncomplicated hypertension, but more frequently in hypertensive patients with renal impairment, especially if they also have a collagen-vascular disease such as systemic lupus erythematosus or scleroderma. " type="negative"><entity charOffset="8:21" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.63.e.0" text="ace inhibitor" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="Another ACE inhibitor," preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="23:32" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.63.e.1" text="captopril" type="Biomedical_Entity"><Normalization><mmtx cui="C0006938" phraseText="captopril," preferredWord="Captopril" semType="phsu, aapp"/><RxNorm RxCui="1998"/></Normalization></entity><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.63.e.0" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.63.e.1"/></sentence><sentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.64" text="Although there were no instances of severe neutropenia (absolute neutrophil count &lt;500/mm3) among patients given moexipril, as with other ACE inhibitors, monitoring of white blood cell counts should be considered for patients who have collagen-vascular disease, especially if the disease is associated with impaired renal function. " type="negative"><entity charOffset="138:152" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.64.e.0" text="ace inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="as with other ACE inhibitors," preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="113:122" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.64.e.1" text="moexipril" type="Biomedical_Entity"><Normalization><mmtx cui="C0066685" phraseText="moexipril," preferredWord="moexipril" semType="phsu, orch"/><RxNorm RxCui="236066"/></Normalization></entity><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.64.e.1" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.64.e.0"/></sentence><sentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.65" text="Available data from clinical trials of moexipril are insufficient to show that moexipril does not cause agranulocytosis at rates similar to captopril." type="negative"><entity charOffset="79:88" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.65.e.0" text="moexipril" type="Biomedical_Entity"><Normalization><mmtx cui="C0066685" phraseText="that moexipril" preferredWord="moexipril" semType="phsu, orch"/><RxNorm RxCui="236066"/></Normalization></entity><entity charOffset="140:149" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.65.e.1" text="captopril" type="Biomedical_Entity"><Normalization><mmtx cui="C0006938" phraseText="similar to captopril." preferredWord="Captopril" semType="phsu, aapp"/><RxNorm RxCui="1998"/></Normalization></entity><entity charOffset="39:48" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.65.e.2" text="moexipril" type="Biomedical_Entity"><Normalization><mmtx cui="C0066685" phraseText="Available data from clinical trials of moexipril" preferredWord="moexipril" semType="phsu, orch"/><RxNorm RxCui="236066"/></Normalization></entity><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.65.e.0" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.65.e.1"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.65.e.2" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.65.e.1"/></sentence><sentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.73" text="Most epidemiologic studies examining fetal abnormalities after exposure to antihypertensive use in the first trimester have not distinguished drugs affecting the renin-angiotensin system from other antihypertensive agents. " type="negative"><entity charOffset="168:179" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.73.e.0" text="angiotensin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003018" phraseText="the renin-angiotensin system from other antihypertensive agents." preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="75:91" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.73.e.1" text="antihypertensive" type="Biomedical_Entity"><Normalization><mmtx cui="C0003364" phraseText="to antihypertensive use" preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><entity charOffset="198:221" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.73.e.2" text="antihypertensive agents" type="Biomedical_Entity"><Normalization><mmtx cui="C0003364" phraseText="the renin-angiotensin system from other antihypertensive agents." preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.73.e.1" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.73.e.0"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.73.e.0" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.73.e.2"/></sentence><sentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.83" text="Reproduction studies with the combination of moexipril hydrochloride and hydrochlorothiazide (ratio 7.5:12.5) indicated that the combination possessed no teratogenic properties up to the lethal dose of 800 mg/kg/day in rats and up to the maternotoxic dose of 160 mg/kg/day in rabbits." type="negative"><entity charOffset="73:92" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.83.e.0" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="45:68" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.83.e.1" text="moexipril hydrochloride" type="Biomedical_Entity"><Normalization><mmtx cui="C0771294" phraseText="studies with the combination of moexipril hydrochloride" preferredWord="Moexipril hydrochloride" semType="phsu, orch"/><RxNorm RxCui="236066"/></Normalization></entity><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.83.e.1" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.83.e.0"/></sentence><sentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.90" text="In patients with mild to moderate cirrhosis given single 15 mg doses of moexipril, the Cmax of moexipril was increased by about 50% and the AUC increased by about 120%, while the Cmax for moexiprilat was decreased by about 50% and the AUC increased by almost 300%. " type="negative"><entity charOffset="188:199" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.90.e.0" text="moexiprilat" type="Biomedical_Entity"><Normalization><mmtx cui="C0209137" phraseText="the Cmax for moexiprilat" preferredWord="moexiprilat" semType="phsu, orch"/><RxNorm RxCui="236066"/></Normalization></entity><entity charOffset="95:104" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.90.e.1" text="moexipril" type="Biomedical_Entity"><Normalization><mmtx cui="C0066685" phraseText="the Cmax of moexipril" preferredWord="moexipril" semType="phsu, orch"/><RxNorm RxCui="236066"/></Normalization></entity><entity charOffset="72:81" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.90.e.2" text="moexipril" type="Biomedical_Entity"><Normalization><mmtx cui="C0066685" phraseText="of moexipril," preferredWord="moexipril" semType="phsu, orch"/><RxNorm RxCui="236066"/></Normalization></entity><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.90.e.1" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.90.e.0"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.90.e.2" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.90.e.0"/></sentence><sentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.95" text="Hydrochlorothiazide, a sulfonamide, can cause an idiosyncratic reaction, resulting in acute transient myopia and acute angle-closure glaucoma. " type="negative"><entity charOffset="0:19" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.95.e.0" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="Hydrochlorothiazide," preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="23:34" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.95.e.1" text="sulfonamide" type="Biomedical_Entity"><Normalization><mmtx cui="C0599503" phraseText="a sulfonamide," preferredWord="Sulfonamide Anti-Infective Agents" semType="orch, antb"/><RxNorm RxCui="1427600"/></Normalization></entity><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.95.e.0" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.95.e.1"/></sentence><sentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.104" text="In clinical trials with moexipril monotherapy, persistent hyperkalemia (serum potassium above 5.4 mEq/L) occurred in approximately 1.3% of hypertensive patients receiving moexipril. " type="negative"><entity charOffset="171:180" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.104.e.0" text="moexipril" type="Biomedical_Entity"><Normalization><mmtx cui="C0066685" phraseText="moexipril." preferredWord="moexipril" semType="phsu, orch"/><RxNorm RxCui="236066"/></Normalization></entity><entity charOffset="24:33" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.104.e.1" text="moexipril" type="Biomedical_Entity"><Normalization><mmtx cui="C0066685" phraseText="with moexipril monotherapy," preferredWord="moexipril" semType="phsu, orch"/><RxNorm RxCui="236066"/></Normalization></entity><entity charOffset="78:87" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.104.e.2" text="potassium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597277" phraseText="(serum potassium above 5.4 mEq/" preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="8588"/></Normalization></entity><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.104.e.2" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.104.e.0"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.104.e.1" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.104.e.2"/></sentence><sentence biomedicalEntities="4" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.105" lineNumber="106" text="Risk factors for the development of hyperkalemia with ACE inhibitors include renal insufficiency, diabetes mellitus, and the concomitant use of potassium-sparing diuretics, potassium supplements, and/or potassium-containing salt substitutes." type="regular"><entity charOffset="54:68" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.105.e.0" text="ACE inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="with ACE inhibitors" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="36:48" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.105.e.1" text="hyperkalemia" type="Specific_Interaction"/><entity charOffset="144:171" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.105.e.3" text="potassium-sparing diuretics" type="Drug_Class"><Normalization><mmtx cui="C0304490" phraseText="the concomitant use of potassium-sparing diuretics," preferredWord="Potassium Sparing Diuretics" semType="phsu"/><RxNorm RxCui="1437061"/></Normalization></entity><entity charOffset="173:194" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.105.e.4" text="potassium supplements" type="Drug_Class"><Normalization><mmtx cui="C0304475" phraseText="potassium supplements," preferredWord="Potassium supplement" semType="inch, phsu"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="203:240" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.105.e.5" text="potassium-containing salt substitutes" type="Substance"><Normalization><mmtx cui="C0597277" phraseText="potassium-containing salt substitutes." preferredWord="Potassium Ion" semType="phsu, elii"/><mmtx cui="C0784217" phraseText="potassium-containing salt substitutes." preferredWord="Salt Substitute" semType="inch, phsu"/><RxNorm RxCui="8588"/></Normalization></entity><drugInteraction id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.105.ddi.1"><interaction trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.105.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.105.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.105.e.4"/></relation><relation type="hasObject"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.105.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.105.e.5"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.105.e.0" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.105.e.3" trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.105.e.1" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.105.e.0" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.105.e.4" trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.105.e.1" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.105.e.0" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.105.e.5" trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.105.e.1" type="Specific_Interaction"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.105.e.3" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.105.e.4"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.105.e.3" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.105.e.5"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.105.e.4" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.105.e.5"/></sentence><sentence biomedicalEntities="2" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.109" lineNumber="108" text="The risk of hypokalemia is greatest in patients with cirrhosis of the liver, in patients experiencing a brisk diuresis, in patients who are receiving inadequate oral intake of electrolytes, and in patients receiving concomitant therapy with corticosteroids or ACTH." type="irregular"><entity charOffset="12:23" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.109.e.0" text="hypokalemia" type="Specific_Interaction"/><entity charOffset="241:256" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.109.e.2" text="corticosteroids" type="Drug_Class"><Normalization><mmtx cui="C0001617" phraseText="concomitant therapy with corticosteroids" preferredWord="Adrenal Cortex Hormones" semType="strd, phsu, horm"/><RxNorm RxCui="1427675"/></Normalization></entity><entity charOffset="260:264" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.109.e.3" text="ACTH" type="Drug"><Normalization><RxNorm RxCui="376"/></Normalization></entity><drugInteraction id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.109.ddi.1"><interaction trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.109.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.109.e.3"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.106" text="Treatment with thiazide diuretics has been associated with hypokalemia, hyponatremia, and hypochloremic alkalosis. "><entity charOffset="15:33" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.106.e.0" text="thiazide diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012802" phraseText="Treatment with thiazide diuretics" preferredWord="Thiazide Diuretics" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.107" text="These disturbances sometimes manifest as one or more of the following: dryness of mouth, thirst, weakness, lethargy, drowsiness, restlessness, muscle pains or cramps, muscular fatigue, hypotension, oliguria, tachycardia, nausea, and vomiting. "/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.108" text="Hypokalemia has also been reported to sensitize or exaggerate the response of the heart to the toxic effects of digitalis. "/></relation><relation type="hasPrecipitant"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.109.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.109.e.2" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.109.e.3"/><pair ddi="true" e1="labelDrug" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.109.e.3"/><pair ddi="true" e1="labelDrug" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.109.e.2"/></sentence><sentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.110" text="The opposite effects of moexipril and hydrochlorothiazide on serum potassium will approximately counterbalance each other in many patients, so that little net effect upon serum potassium will be seen. " type="negative"><entity charOffset="177:186" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.110.e.0" text="potassium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597277" phraseText="that little net effect upon serum potassium" preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="24:33" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.110.e.1" text="moexipril" type="Biomedical_Entity"><Normalization><mmtx cui="C0066685" phraseText="The opposite effects of moexipril" preferredWord="moexipril" semType="phsu, orch"/><RxNorm RxCui="236066"/></Normalization></entity><entity charOffset="38:57" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.110.e.2" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="hydrochlorothiazide on serum potassium" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="67:76" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.110.e.3" text="potassium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597277" phraseText="hydrochlorothiazide on serum potassium" preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="8588"/></Normalization></entity><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.110.e.1" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.110.e.0"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.110.e.2" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.110.e.0"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.110.e.1" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.110.e.2"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.110.e.1" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.110.e.3"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.110.e.2" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.110.e.3"/></sentence><sentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.111" text="Initial and periodic determinations of serum electrolytes to detect possible electrolyte imbalance should be performed at appropriate intervals." type="negative"><entity charOffset="45:57" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.111.e.0" text="electrolytes" type="Biomedical_Entity"><Normalization><mmtx cui="C3536863" phraseText="periodic determinations of serum electrolytes to" preferredWord="Electrolyte [EPC]" semType="phsu"/><RxNorm RxCui="3793"/></Normalization></entity><entity charOffset="77:88" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.111.e.1" text="electrolyte" type="Biomedical_Entity"><Normalization><mmtx cui="C0013832" phraseText="possible electrolyte imbalance" preferredWord="Electrolytes" semType="inch, phsu"/><RxNorm RxCui="3793"/></Normalization></entity><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.111.e.0" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.111.e.1"/></sentence><sentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.116" text="Calcium excretion is reduced by thiazides. " type="negative"><entity charOffset="0:7" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.116.e.0" text="calcium" type="Biomedical_Entity"><Normalization><mmtx cui="C0006675" phraseText="Calcium excretion" preferredWord="Calcium" semType="bacs, phsu, elii"/><RxNorm RxCui="1895"/></Normalization></entity><entity charOffset="32:41" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.116.e.1" text="thiazides" type="Biomedical_Entity"><Normalization><mmtx cui="C0541746" phraseText="reduced by thiazides." preferredWord="Thiazides" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.116.e.0" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.116.e.1"/></sentence><sentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.121" text="Thiazide diuretics may reduce glucose tolerance and may raise serum levels of cholesterol, triglycerides, and uric acid. " type="negative"><entity charOffset="0:18" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.121.e.0" text="thiazide diuretics" type="Biomedical_Entity"><Normalization><mmtx cui="C0012802" phraseText="Thiazide diuretics" preferredWord="Thiazide Diuretics" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><entity charOffset="30:37" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.121.e.1" text="glucose" type="Biomedical_Entity"><Normalization><mmtx cui="C0017725" phraseText="glucose tolerance" preferredWord="Glucose" semType="bacs, phsu, carb"/><RxNorm RxCui="4850"/></Normalization></entity><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.121.e.0" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.121.e.1"/></sentence><sentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.124" text="In patients undergoing major surgery or during anesthesia with agents that produce hypotension, moexipril may block the effects of compensatory renin release. " type="negative"><entity charOffset="96:105" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.124.e.0" text="moexipril" type="Biomedical_Entity"><Normalization><mmtx cui="C0066685" phraseText="moexipril" preferredWord="moexipril" semType="phsu, orch"/><RxNorm RxCui="236066"/></Normalization></entity><entity charOffset="47:57" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.124.e.1" text="anesthesia" type="Biomedical_Entity"><Normalization><mmtx cui="C0002932" phraseText="or during anesthesia" preferredWord="Anesthetics" semType="phsu"/><RxNorm RxCui="239756"/></Normalization></entity><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.124.e.1" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.124.e.0"/></sentence><sentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.131" text="Potassium Supplements and Potassium-Sparing Diuretics" type="negative"><entity charOffset="26:53" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.131.e.0" text="potassium-sparing diuretics" type="Biomedical_Entity"><Normalization><mmtx cui="C0304490" phraseText="Potassium-Sparing Diuretics" preferredWord="Potassium Sparing Diuretics" semType="phsu"/><RxNorm RxCui="1437061"/></Normalization></entity><entity charOffset="0:21" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.131.e.1" text="potassium supplements" type="Biomedical_Entity"><Normalization><mmtx cui="C0304475" phraseText="Potassium Supplements" preferredWord="Potassium supplement" semType="inch, phsu"/><RxNorm RxCui="8588"/></Normalization></entity><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.131.e.1" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.131.e.0"/></sentence><sentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.132" text="As noted above (Serum Electrolyte Imbalances), the net effect of uniretic may be to elevate a patient's serum potassium, to reduce it, or to leave it unchanged. " type="negative"><entity charOffset="22:33" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.132.e.0" text="electrolyte" type="Biomedical_Entity"><Normalization><mmtx cui="C3536863" phraseText="(Serum Electrolyte Imbalances" preferredWord="Electrolyte [EPC]" semType="phsu"/><RxNorm RxCui="3793"/></Normalization></entity><entity charOffset="65:73" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.132.e.1" text="uniretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0724120" phraseText="the net effect of uniretic" preferredWord="Uniretic" semType="phsu, orch"/><RxNorm RxCui="220670"/></Normalization></entity><entity charOffset="110:119" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.132.e.2" text="potassium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597277" phraseText="a patient's serum potassium," preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="8588"/></Normalization></entity><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.132.e.0" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.132.e.1"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.132.e.0" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.132.e.2"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.132.e.1" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.132.e.2"/></sentence><sentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.133" text="Potassium-sparing diuretics (spironolactone, amiloride, triamterene) or potassium supplements can increase the risk of hyperkalemia. " type="negative"><entity charOffset="45:54" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.133.e.0" text="amiloride" type="Biomedical_Entity"><Normalization><mmtx cui="C0002502" phraseText="amiloride," preferredWord="Amiloride" semType="phsu, orch"/><RxNorm RxCui="142424"/></Normalization></entity><entity charOffset="56:67" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.133.e.1" text="triamterene" type="Biomedical_Entity"><Normalization><mmtx cui="C0040869" phraseText="triamterene" preferredWord="Triamterene" semType="phsu, orch"/><RxNorm RxCui="10763"/></Normalization></entity><entity charOffset="72:93" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.133.e.2" text="potassium supplements" type="Biomedical_Entity"><Normalization><mmtx cui="C0304475" phraseText="potassium supplements" preferredWord="Potassium supplement" semType="inch, phsu"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="29:43" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.133.e.3" text="spironolactone" type="Biomedical_Entity"><Normalization><mmtx cui="C0037982" phraseText="(spironolactone," preferredWord="Spironolactone" semType="strd, phsu"/><RxNorm RxCui="9997"/></Normalization></entity><entity charOffset="0:27" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.133.e.4" text="potassium-sparing diuretics" type="Biomedical_Entity"><Normalization><mmtx cui="C0304490" phraseText="Potassium-sparing diuretics" preferredWord="Potassium Sparing Diuretics" semType="phsu"/><RxNorm RxCui="1437061"/></Normalization></entity><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.133.e.0" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.133.e.1"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.133.e.0" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.133.e.2"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.133.e.3" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.133.e.0"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.133.e.4" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.133.e.0"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.133.e.1" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.133.e.2"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.133.e.3" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.133.e.1"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.133.e.4" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.133.e.1"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.133.e.3" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.133.e.2"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.133.e.4" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.133.e.2"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.133.e.4" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.133.e.3"/></sentence><sentence biomedicalEntities="0" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.134" lineNumber="132" text="If concomitant use of such agents is indicated, they should be given with caution, and the patient's serum potassium should be monitored." type="irregular"><anaphoraRelation><antecedentSentence ID="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.133" Text="Potassium-sparing diuretics (spironolactone, amiloride, triamterene) or potassium supplements can increase the risk of hyperkalemia. "/><anaphoraEntity charOffset="22:33" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.134.e.0" text="such agents" type="Expression"/><antecedentEntity charOffset="0:27" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.133.e.0" text="Potassium-sparing diuretics" type="Drug_Class"/></anaphoraRelation><anaphoraRelation><antecedentSentence ID="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.133" Text="Potassium-sparing diuretics (spironolactone, amiloride, triamterene) or potassium supplements can increase the risk of hyperkalemia. "/><anaphoraEntity charOffset="22:33" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.134.e.0" text="such agents" type="Expression"/><antecedentEntity charOffset="72:93" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.133.e.4" text="potassium supplements" type="Drug_Class"/></anaphoraRelation><entity charOffset="91:98|127:136" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.134.e.3" text="patient monitored" type="Caution_Interaction"/><drugInteraction id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.134.ddi.1"><interaction trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.134.e.3"><relations><relation type="hasPrecipitant"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.134.e.0"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.132" text="As noted above (Serum Electrolyte Imbalances), the net effect of uniretic may be to elevate a patient's serum potassium, to reduce it, or to leave it unchanged. "><entity charOffset="65:73" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.132.e.0" text="uniretic" type="Drug"><Normalization><mmtx cui="C0724120" phraseText="the net effect of uniretic" preferredWord="Uniretic" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.133" text="Potassium-sparing diuretics (spironolactone, amiloride, triamterene) or potassium supplements can increase the risk of hyperkalemia. "/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.134.e.0"/></sentence><sentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.136" text="Interaction studies with warfarin failed to identify any clinically important effect of moexipril monotherapy on the serum concentrations of the anticoagulant or on its anticoagulant effect." type="negative"><entity charOffset="145:158" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.136.e.0" text="anticoagulant" type="Biomedical_Entity"><Normalization><mmtx cui="C3536711" phraseText="of the anticoagulant" preferredWord="Anti-coagulant [EPC]" semType="phsu"/><RxNorm RxCui="923"/></Normalization></entity><entity charOffset="88:97" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.136.e.1" text="moexipril" type="Biomedical_Entity"><Normalization><mmtx cui="C0066685" phraseText="any clinically important effect of moexipril monotherapy" preferredWord="moexipril" semType="phsu, orch"/><RxNorm RxCui="236066"/></Normalization></entity><entity charOffset="25:33" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.136.e.2" text="warfarin" type="Biomedical_Entity"><Normalization><mmtx cui="C0043031" phraseText="studies with warfarin" preferredWord="Warfarin" semType="phsu, orch, hops"/><RxNorm RxCui="11289"/></Normalization></entity><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.136.e.1" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.136.e.0"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.136.e.2" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.136.e.0"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.136.e.2" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.136.e.1"/></sentence><sentence biomedicalEntities="3" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.138" lineNumber="140" text="Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving ACE inhibitors during therapy with lithium. " type="regular"><entity charOffset="105:119" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.138.e.0" text="ACE inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="ACE inhibitors during therapy" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="16:23" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.138.e.1" text="lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="Increased serum lithium levels" preferredWord="Lithium" semType="phsu, elii"/><mmtx cui="C0023870" phraseText="Increased serum lithium levels" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><entity charOffset="0:15|24:30" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.138.e.2" text="Increased serum levels" type="Increase_Interaction"/><entity charOffset="55:63" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.138.e.4" text="toxicity" type="Increase_Interaction"><Normalization><mmtx cui="C0858786" phraseText="symptoms of lithium toxicity" preferredWord="toxic symptom" semType="sosy"/></Normalization></entity><entity charOffset="47:54" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.138.e.6" text="lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="symptoms of lithium toxicity" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><drugInteraction id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.138.ddi.1"><interaction trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.138.e.2"><relations><relation type="hasObject"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.138.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.138.e.0"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.138.ddi.2"><interaction trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.138.e.4"><relations><relation type="hasObject"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.138.e.6"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.138.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.138.e.1" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.138.e.0" trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.138.e.2" type="Increase_Interaction"/><pair ddi="true" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.138.e.6" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.138.e.0" trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.138.e.4" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="5" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.139" lineNumber="140" text="Because renal clearance of lithium is reduced by thiazides, the risk of lithium toxicity is presumably raised further when, as in therapy with uniretic, a thiazide diuretic is coadministered with the ACE inhibitor. " type="regular"><entity charOffset="27:34" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.139.e.0" text="lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="renal clearance of lithium" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><entity charOffset="49:58" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.139.e.1" text="thiazides" type="Drug_Class"><Normalization><mmtx cui="C0541746" phraseText="reduced by thiazides," preferredWord="Thiazides" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><entity charOffset="8:23|38:45" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.139.e.2" text="renal clearance reduced" type="Increase_Interaction"/><entity charOffset="80:88" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.139.e.4" text="toxicity" type="Increase_Interaction"/><entity charOffset="72:79" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.139.e.6" text="lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="the risk of lithium toxicity" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><entity charOffset="143:151" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.139.e.7" text="uniretic" type="Drug"><Normalization><mmtx cui="C0724120" phraseText="with uniretic," preferredWord="Uniretic" semType="phsu, orch"/><RxNorm RxCui="220670"/></Normalization></entity><entity charOffset="155:213" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.139.e.8" text="thiazide diuretic is coadministered with the ACE inhibitor" type="Drug_Class"><Normalization><mmtx cui="C0012802" phraseText="a thiazide diuretic" preferredWord="Thiazide Diuretics" semType="phsu, orch"/><mmtx cui="C3536861" phraseText="a thiazide diuretic" preferredWord="Thiazide Diuretic [EPC]" semType="phsu"/><mmtx cui="C0003015" phraseText="coadministered with the ACE inhibitor." preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="141801"/></Normalization></entity><drugClassMembership drug="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.139.e.7" drugClass="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.139.e.8"/><drugInteraction id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.139.ddi.1"><interaction trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.139.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.139.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.139.e.0"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.139.ddi.2"><interaction trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.139.e.4"><relations><relation type="hasPrecipitant"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.139.e.8"/></relation><relation type="hasObject"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.139.e.6"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.139.e.0" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.139.e.1" trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.139.e.2" type="Increase_Interaction"/><pair ddi="true" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.139.e.6" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.139.e.8" trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.139.e.4" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="1" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.140" lineNumber="140" text="These drugs should be coadministered with caution, and frequent monitoring of serum lithium levels is recommended." type="irregular"><anaphoraRelation><antecedentSentence ID="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.139" Text="Because renal clearance of lithium is reduced by thiazides, the risk of lithium toxicity is presumably raised further when, as in therapy with uniretic, a thiazide diuretic is coadministered with the ACE inhibitor. "/><anaphoraEntity charOffset="0:11" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.140.e.0" text="These drugs" type="Expression"/><antecedentEntity charOffset="155:213" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.139.e.8" text="thiazide diuretic is coadministered with the ACE inhibitor" type="Drug_Class"/></anaphoraRelation><entity charOffset="64:74" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.140.e.2" text="monitoring" type="Caution_Interaction"/><entity charOffset="84:91" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.140.e.4" text="lithium" type="Drug"><Normalization><mmtx cui="C1441405" phraseText="frequent monitoring of serum lithium levels" preferredWord="Lithium.serum" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><drugInteraction id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.140.ddi.1"><interaction trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.140.e.2"><relations><relation type="hasObject"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.140.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.140.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.140.e.0" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.140.e.4" trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.140.e.2" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.142" lineNumber="144" text="Nitritoid reactions (symptoms include facial flushing, nausea, vomiting, and hypotension) have been reported rarely in patients on therapy with injectable gold (sodium aurothiomalate) and concomitant ACE inhibitor therapy including uniretic." type="regular"><entity charOffset="0:19" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.142.e.0" text="Nitritoid reactions" type="Specific_Interaction"><Normalization><mmtx cui="C0948404" phraseText="Nitritoid reactions" preferredWord="Nitritoid reaction" semType="dsyn"/></Normalization></entity><entity charOffset="38:53" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.142.e.2" text="facial flushing" type="Specific_Interaction"><Normalization><mmtx cui="C0016382" phraseText="facial flushing," preferredWord="Flushing" semType="sosy"/></Normalization></entity><entity charOffset="55:61" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.142.e.4" text="nausea" type="Specific_Interaction"><Normalization><mmtx cui="C0027497" phraseText="nausea," preferredWord="Nausea" semType="sosy"/></Normalization></entity><entity charOffset="63:71" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.142.e.6" text="vomiting" type="Specific_Interaction"><Normalization><mmtx cui="C0042963" phraseText="vomiting" preferredWord="Vomiting" semType="sosy"/></Normalization></entity><entity charOffset="77:88" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.142.e.8" text="hypotension" type="Specific_Interaction"/><entity charOffset="161:182" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.142.e.10" text="sodium aurothiomalate" type="Drug"><Normalization><mmtx cui="C0018034" phraseText="with injectable gold (sodium aurothiomalate" preferredWord="Gold Sodium Thiomalate" semType="phsu, orch"/><RxNorm RxCui="9853"/></Normalization></entity><entity charOffset="200:213" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.142.e.11" text="ACE inhibitor" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="concomitant ACE inhibitor therapy" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="232:240" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.142.e.12" text="uniretic" type="Drug"><Normalization><mmtx cui="C0724120" phraseText="uniretic." preferredWord="Uniretic" semType="phsu, orch"/><RxNorm RxCui="220670"/></Normalization></entity><drugClassMembership drug="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.142.e.12" drugClass="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.142.e.11"/><drugInteraction id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.142.ddi.1"><interaction trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.142.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.142.e.10"/></relation><relation type="hasObject"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.142.e.11"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.142.ddi.2"><interaction trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.142.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.142.e.10"/></relation><relation type="hasObject"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.142.e.11"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.142.ddi.3"><interaction trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.142.e.4"><relations><relation type="hasPrecipitant"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.142.e.10"/></relation><relation type="hasObject"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.142.e.11"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.142.ddi.4"><interaction trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.142.e.6"><relations><relation type="hasPrecipitant"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.142.e.10"/></relation><relation type="hasObject"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.142.e.11"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.142.ddi.5"><interaction trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.142.e.8"><relations><relation type="hasPrecipitant"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.142.e.10"/></relation><relation type="hasObject"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.142.e.11"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.142.e.10" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.142.e.11" trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.142.e.0" type="Specific_Interaction"/></sentence><sentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.143" text="Alcohol, Barbiturates, or Narcotics" type="negative"><entity charOffset="9:21" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.143.e.0" text="barbiturates" type="Biomedical_Entity"><Normalization><mmtx cui="C0004745" phraseText="Barbiturates," preferredWord="Barbiturates" semType="phsu, orch"/><RxNorm RxCui="1437144"/></Normalization></entity><entity charOffset="26:35" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.143.e.1" text="narcotics" type="Biomedical_Entity"><Normalization><mmtx cui="C0027415" phraseText="Narcotics" preferredWord="Narcotics" semType="phsu, hops"/><RxNorm RxCui="992359"/></Normalization></entity><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.143.e.0" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.143.e.1"/></sentence><sentence biomedicalEntities="4" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.144" lineNumber="148" text="Potentiation of orthostatic hypotension may occur in patients on thiazide diuretic therapy with concomitant use of alcohol, barbiturates, or narcotics." type="regular"><entity charOffset="0:39" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.144.e.0" text="Potentiation of orthostatic hypotension" type="Specific_Interaction"><Normalization><mmtx cui="C0149746" phraseText="Potentiation of orthostatic hypotension" preferredWord="Orthostasis" semType="sosy"/></Normalization></entity><entity charOffset="65:82" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.144.e.2" text="thiazide diuretic" type="Drug_Class"><Normalization><mmtx cui="C0012802" phraseText="on thiazide diuretic therapy" preferredWord="Thiazide Diuretics" semType="phsu, orch"/><mmtx cui="C3536861" phraseText="on thiazide diuretic therapy" preferredWord="Thiazide Diuretic [EPC]" semType="phsu"/><RxNorm RxCui="141801"/></Normalization></entity><entity charOffset="115:122" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.144.e.3" text="alcohol" type="Substance"><Normalization><mmtx cui="C0001975" phraseText="of alcohol," preferredWord="Alcohols" semType="phsu, orch"/><RxNorm RxCui="448"/></Normalization></entity><entity charOffset="124:136" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.144.e.4" text="barbiturates" type="Drug_Class"><Normalization><mmtx cui="C0004745" phraseText="barbiturates," preferredWord="Barbiturates" semType="phsu, orch"/><RxNorm RxCui="1437144"/></Normalization></entity><entity charOffset="141:150" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.144.e.5" text="narcotics" type="Drug_Class"><Normalization><mmtx cui="C0027415" phraseText="narcotics." preferredWord="Narcotics" semType="phsu, hops"/><RxNorm RxCui="992359"/></Normalization></entity><drugInteraction id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.144.ddi.1"><interaction trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.144.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.144.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.144.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.144.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.144.e.5"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.144.e.2" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.144.e.3" trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.144.e.0" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.144.e.2" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.144.e.4" trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.144.e.0" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.144.e.2" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.144.e.5" trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.144.e.0" type="Specific_Interaction"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.144.e.3" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.144.e.4"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.144.e.3" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.144.e.5"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.144.e.4" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.144.e.5"/></sentence><sentence biomedicalEntities="3" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.146" lineNumber="152" text="Use of thiazide diuretics concomitantly with antidiabetic agents (oral agents and insulin) may require dosage adjustment of the antidiabetic agent. " type="regular"><anaphoraRelation><anaphoraEntity charOffset="128:146" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.146.e.4" text="antidiabetic agent" type="Expression"/><antecedentEntity charOffset="45-77" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.146.e.2" text="antidiabetic agents oral agents" type="Drug_Class"/></anaphoraRelation><anaphoraRelation><anaphoraEntity charOffset="128:146" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.146.e.4" text="antidiabetic agent" type="Expression"/><antecedentEntity charOffset="82-89" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.146.e.3" text="insulin" type="Drug"/></anaphoraRelation><entity charOffset="103:120" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.146.e.0" text="dosage adjustment" type="Caution_Interaction"/><entity charOffset="45:64|66:77" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.146.e.2" text="antidiabetic agents oral agents" type="Drug_Class"><Normalization><mmtx cui="C0935929" phraseText="with antidiabetic agents" preferredWord="Antidiabetics" semType="phsu"/><mmtx cui="C1254351" phraseText="(oral agents" preferredWord="Pharmacologic Substance" semType="phsu"/><RxNorm RxCui="282360"/></Normalization></entity><entity charOffset="82:89" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.146.e.3" text="insulin" type="Drug"><Normalization><mmtx cui="C0021641" phraseText="insulin" preferredWord="Insulin" semType="phsu, aapp, horm"/><mmtx cui="C1533581" phraseText="insulin" preferredWord="Recombinant Insulin" semType="phsu, aapp, horm"/><mmtx cui="C1579433" phraseText="insulin" preferredWord="Insulin [EPC]" semType="phsu"/><RxNorm RxCui="5856"/></Normalization></entity><entity charOffset="7:25" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.146.e.6" text="thiazide diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012802" phraseText="Use of thiazide diuretics concomitantly" preferredWord="Thiazide Diuretics" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><drugInteraction id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.146.ddi.1"><interaction trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.146.e.0"><relations><relation type="hasObject"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.146.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.146.e.6"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.146.e.6" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.146.e.4" trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.146.e.0" type="Caution_Interaction"/></sentence><sentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.147" text="Moexipril has been used in clinical trials concomitantly with oral hypoglycemic agents and there was no evidence of any clinically important adverse interactions." type="negative"><entity charOffset="0:9" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.147.e.0" text="moexipril" type="Biomedical_Entity"><Normalization><mmtx cui="C0066685" phraseText="Moexipril" preferredWord="moexipril" semType="phsu, orch"/><RxNorm RxCui="236066"/></Normalization></entity><entity charOffset="62:86" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.147.e.1" text="oral hypoglycemic agents" type="Biomedical_Entity"><Normalization><mmtx cui="C0359086" phraseText="with oral hypoglycemic agents" preferredWord="Oral hypoglycemic" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.147.e.0" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.147.e.1"/></sentence><sentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.148" text="Cholestyramine and Colestipol Resins" type="negative"><entity charOffset="19:29" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.148.e.0" text="colestipol" type="Biomedical_Entity"><Normalization><mmtx cui="C0009279" phraseText="Colestipol Resins" preferredWord="Colestipol" semType="phsu, orch"/><RxNorm RxCui="104485"/></Normalization></entity><entity charOffset="0:14" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.148.e.1" text="cholestyramine" type="Biomedical_Entity"><Normalization><mmtx cui="C0008402" phraseText="Cholestyramine" preferredWord="Cholestyramine Resin" semType="phsu, orch"/><RxNorm RxCui="2447"/></Normalization></entity><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.148.e.1" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.148.e.0"/></sentence><sentence biomedicalEntities="3" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.150" lineNumber="156" text="Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85% and 43%, respectively." type="regular"><entity charOffset="92:113" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.150.e.0" text="reduce its absorption" type="Decrease_Interaction"/><entity charOffset="68:87" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.150.e.2" text="hydrochlorothiazide" type="Drug"><Normalization><mmtx cui="C0020261" phraseText="the hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="23:37" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.150.e.3" text="cholestyramine" type="Drug"><Normalization><mmtx cui="C0008402" phraseText="Single doses of either cholestyramine" preferredWord="Cholestyramine Resin" semType="phsu, orch"/><RxNorm RxCui="2447"/></Normalization></entity><entity charOffset="41:58" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.150.e.4" text="colestipol resins" type="Drug_Class"><Normalization><mmtx cui="C0009279" phraseText="colestipol resins" preferredWord="Colestipol" semType="phsu, orch"/><RxNorm RxCui="104485"/></Normalization></entity><drugInteraction id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.150.ddi.1"><interaction trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.150.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.150.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.150.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.150.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.150.e.3" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.150.e.2" trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.150.e.0" type="Decrease_Interaction"/><pair ddi="true" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.150.e.4" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.150.e.2" trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.150.e.0" type="Decrease_Interaction"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.150.e.3" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.150.e.4"/></sentence><sentence biomedicalEntities="3" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.152" lineNumber="160" text="Use of thiazide diuretics concomitantly with corticosteroids or ACTH may intensify electrolyte depletion, particularly hypokalemia." type="regular"><entity charOffset="7:25" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.152.e.0" text="thiazide diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012802" phraseText="Use of thiazide diuretics concomitantly" preferredWord="Thiazide Diuretics" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><entity charOffset="45:60" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.152.e.1" text="corticosteroids" type="Drug_Class"><Normalization><mmtx cui="C0001617" phraseText="with corticosteroids" preferredWord="Adrenal Cortex Hormones" semType="strd, phsu, horm"/><RxNorm RxCui="1427675"/></Normalization></entity><entity charOffset="64:68" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.152.e.2" text="ACTH" type="Drug"><Normalization><RxNorm RxCui="376"/></Normalization></entity><entity charOffset="73:104" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.152.e.3" text="intensify electrolyte depletion" type="Specific_Interaction"/><entity charOffset="119:130" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.152.e.5" text="hypokalemia" type="Specific_Interaction"/><drugInteraction id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.152.ddi.1"><interaction trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.152.e.3"><relations><relation type="hasPrecipitant"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.152.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.152.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.152.e.0"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.152.ddi.2"><interaction trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.152.e.5"><relations><relation type="hasPrecipitant"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.152.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.152.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.152.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.152.e.0" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.152.e.1" trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.152.e.3" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.152.e.0" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.152.e.2" trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.152.e.3" type="Specific_Interaction"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.152.e.1" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.152.e.2"/></sentence><sentence biomedicalEntities="2" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.154" lineNumber="164" text="Thiazide diuretics may decrease arterial responsiveness to pressor amines" type="regular"><entity charOffset="0:18" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.154.e.0" text="Thiazide diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012802" phraseText="Thiazide diuretics" preferredWord="Thiazide Diuretics" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><entity charOffset="59:73" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.154.e.1" text="pressor amines" type="Drug_Class"><Normalization><mmtx cui="C0237795" phraseText="arterial responsiveness to pressor amines" preferredWord="Pressors" semType="phsu"/><RxNorm RxCui="203344"/></Normalization></entity><entity charOffset="23:55" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.154.e.3" text="decrease arterial responsiveness" type="Specific_Interaction"/><drugClassMembership drug="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.155.e.0" drugClass="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.154.e.1"/><drugInteraction id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.154.ddi.1"><interaction trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.154.e.3"><relations><relation type="hasObject"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.154.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.154.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.154.e.0" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.154.e.1" trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.154.e.3" type="Specific_Interaction"/></sentence><sentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.155" text="(e.g. norepinephrine), but not enough to preclude effectiveness of the pressor agent for therapeutic use." type="negative"><entity charOffset="6:20" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.155.e.0" text="norepinephrine" type="Biomedical_Entity"><Normalization><mmtx cui="C0028351" phraseText="e.g. norepinephrine" preferredWord="Norepinephrine" semType="phsu, orch, nsba"/><RxNorm RxCui="7508"/></Normalization></entity><entity charOffset="71:78" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.155.e.1" text="pressor" type="Biomedical_Entity"><Normalization><mmtx cui="C0237795" phraseText="effectiveness of the pressor agent" preferredWord="Pressors" semType="phsu"/><RxNorm RxCui="203344"/></Normalization></entity><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.155.e.0" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.155.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.157" lineNumber="169" text="Thiazide diuretics may increase the responsiveness to tubocurarine." type="regular"><entity charOffset="0:18" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.157.e.0" text="Thiazide diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012802" phraseText="Thiazide diuretics" preferredWord="Thiazide Diuretics" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><entity charOffset="54:66" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.157.e.1" text="tubocurarine" type="Drug"><Normalization><mmtx cui="C0041345" phraseText="the responsiveness to tubocurarine." preferredWord="Tubocurarine" semType="phsu, orch"/><RxNorm RxCui="82115"/></Normalization></entity><entity charOffset="23:50" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.157.e.2" text="increase the responsiveness" type="Increase_Interaction"/><drugInteraction id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.157.ddi.1"><interaction trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.157.e.2"><relations><relation type="hasObject"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.157.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.157.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.157.e.0" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.157.e.1" trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.157.e.2" type="Increase_Interaction"/></sentence><sentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.158" text="Non-steroidal Anti-Inflammatory Agents including Selective Cyclooxygenase-2 Inhibitors (COX-2 Inhibitors)" type="negative"><entity charOffset="88:104" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.158.e.0" text="cox-2 inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C1257954" phraseText="(COX-2 Inhibitors" preferredWord="Cyclooxygenase 2 Inhibitors" semType="phsu, orch"/><RxNorm RxCui="382306"/></Normalization></entity><entity charOffset="59:86" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.158.e.1" text="cyclooxygenase-2 inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C1257954" phraseText="Selective Cyclooxygenase-2 Inhibitors" preferredWord="Cyclooxygenase 2 Inhibitors" semType="phsu, orch"/><RxNorm RxCui="119049"/></Normalization></entity><entity charOffset="0:38" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.158.e.2" text="non-steroidal anti-inflammatory agents" type="Biomedical_Entity"><Normalization><mmtx cui="C0003211" phraseText="Non-steroidal Anti-Inflammatory Agents" preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="1005832"/></Normalization></entity><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.158.e.2" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.158.e.0"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.158.e.2" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.158.e.1"/></sentence><sentence biomedicalEntities="4" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.159" lineNumber="173" text="In patients who are elderly, volume-depleted (including those on diuretic therapy), or with compromised renal function, co-administration of NSAIDS, including selective COX-2 inhibitors, with ACE inhibitors, including moexipril, may result in deterioration of renal function, including possible acute renal failure. " type="regular"><entity charOffset="20:27" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.159.e.0" text="elderly" type="SPAN"/><entity charOffset="29:44" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.159.e.1" text="volume-depleted" type="SPAN"/><entity charOffset="65:81" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.159.e.2" text="diuretic therapy" type="SPAN"/><entity charOffset="92:118" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.159.e.3" text="compromised renal function" type="SPAN"/><entity charOffset="141:147" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.159.e.4" text="NSAIDS" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="co-administration of NSAIDS," preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><entity charOffset="159:185" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.159.e.5" text="selective COX-2 inhibitors" type="Drug_Class"><Normalization><mmtx cui="C1257954" phraseText="selective COX-2 inhibitors," preferredWord="Cyclooxygenase 2 Inhibitors" semType="phsu, orch"/><RxNorm RxCui="1431714"/></Normalization></entity><entity charOffset="192:206" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.159.e.6" text="ACE inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="with ACE inhibitors," preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="218:227" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.159.e.7" text="moexipril" type="Drug"><Normalization><mmtx cui="C0066685" phraseText="moexipril," preferredWord="moexipril" semType="phsu, orch"/><RxNorm RxCui="236066"/></Normalization></entity><entity charOffset="243:274" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.159.e.10" text="deterioration of renal function" type="Specific_Interaction"/><entity charOffset="295:314" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.159.e.12" text="acute renal failure" type="Specific_Interaction"><Normalization><mmtx cui="C0022660" phraseText="possible acute renal failure." preferredWord="Kidney Failure, Acute" semType="dsyn"/></Normalization></entity><drugClassMembership drug="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.159.e.7" drugClass="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.159.e.6"/><classClassMembership drugClass="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.159.e.5"/><drugInteraction id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.159.ddi.1"><interaction trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.159.e.10"><relations><relation type="hasContext"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.159.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.159.e.6"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.159.e.4"/></relation><relation type="hasContext"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.159.e.2"/></relation><relation type="hasContext"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.159.e.1"/></relation><relation type="hasContext"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.159.e.0"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.159.ddi.2"><interaction trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.159.e.12"><relations><relation type="hasContext"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.159.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.159.e.6"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.159.e.4"/></relation><relation type="hasContext"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.159.e.2"/></relation><relation type="hasContext"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.159.e.1"/></relation><relation type="hasContext"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.159.e.0"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.159.e.3, Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.159.e.2, Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.159.e.1, Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.159.e.0" ddi="true" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.159.e.4" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.159.e.6" trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.159.e.10" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.161" lineNumber="173" text="Monitor renal function periodically in patients receiving moexipril and NSAID therapy." type="regular"><entity charOffset="0:7" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.161.e.0" text="Monitor" type="Caution_Interaction"/><entity charOffset="58:67" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.161.e.2" text="moexipril" type="Drug"><Normalization><mmtx cui="C0066685" phraseText="moexipril" preferredWord="moexipril" semType="phsu, orch"/><RxNorm RxCui="236066"/></Normalization></entity><entity charOffset="72:77" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.161.e.3" text="NSAID" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="NSAID therapy." preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><drugInteraction id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.161.ddi.1"><interaction trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.161.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.161.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.161.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.161.e.2" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.161.e.3" trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.161.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="4" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.162" lineNumber="175" text="The antihypertensive effect of ACE inhibitors and hydrochlorothiazide, as well as the diuretic and natriuretic effects of hydrochlorothiazide, may be attenuated by NSAIDS." type="regular"><entity charOffset="31:45" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.162.e.0" text="ACE inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="The antihypertensive effect of ACE inhibitors" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="50:69" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.162.e.1" text="hydrochlorothiazide" type="Drug"><Normalization><mmtx cui="C0020261" phraseText="hydrochlorothiazide," preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="4:27|150:160" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.162.e.2" text="antihypertensive effect attenuated" type="Specific_Interaction"/><entity charOffset="164:170" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.162.e.4" text="NSAIDS" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="attenuated by NSAIDS." preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><entity charOffset="86:94|111:118|150:160" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.162.e.5" text="diuretic effects attenuated" type="Specific_Interaction"/><entity charOffset="99:118|150:160" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.162.e.7" text="natriuretic effects attenuated" type="Specific_Interaction"/><entity charOffset="122:141" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.162.e.9" text="hydrochlorothiazide" type="Drug"><Normalization><mmtx cui="C0020261" phraseText="natriuretic effects of hydrochlorothiazide," preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><drugInteraction id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.162.ddi.1"><interaction trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.162.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.162.e.4"/></relation><relation type="hasObject"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.162.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.162.e.1"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.162.ddi.2"><interaction trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.162.e.5"><relations><relation type="hasPrecipitant"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.162.e.4"/></relation><relation type="hasObject"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.162.e.9"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.162.ddi.3"><interaction trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.162.e.7"><relations><relation type="hasPrecipitant"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.162.e.4"/></relation><relation type="hasObject"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.162.e.9"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.162.e.0" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.162.e.4" trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.162.e.2" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.162.e.1" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.162.e.4" trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.162.e.2" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.162.e.9" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.162.e.4" trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.162.e.5" type="Specific_Interaction"/></sentence><sentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.163" text="Dual Blockade of the Renin-Angiotensin System (RAS)" type="negative"><entity charOffset="27:38" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.163.e.0" text="angiotensin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003018" phraseText="Dual Blockade of the Renin-Angiotensin System" preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="5:13" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.163.e.1" text="blockade" type="Biomedical_Entity"><Normalization><mmtx cui="C3540676" phraseText="Dual Blockade of the Renin-Angiotensin System" preferredWord="Blockade" semType="phsu"/><RxNorm RxCui="1423936"/></Normalization></entity><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.163.e.1" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.163.e.0"/></sentence><sentence biomedicalEntities="3" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.164" lineNumber="179" text="Dual blockade of the RAS with angiotensin receptor blockers, ACE inhibitors, or aliskiren is associated with increased risks of hypotension, hyperkalemia, and changes in renal function (including acute renal failure) compared to monotherapy. " type="irregular"><entity charOffset="30:59" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.164.e.0" text="angiotensin receptor blockers" type="Drug_Class"><Normalization><mmtx cui="C0521942" phraseText="with angiotensin receptor blockers," preferredWord="Angiotensin II receptor antagonist" semType="phsu"/><mmtx cui="C0815017" phraseText="with angiotensin receptor blockers," preferredWord="Angiotensin Receptor Antagonists" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="61:75" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.164.e.1" text="ACE inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="ACE inhibitors," preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="80:89" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.164.e.2" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="aliskiren" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="128:139" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.164.e.3" text="hypotension" type="Specific_Interaction"/><entity charOffset="141:153" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.164.e.5" text="hyperkalemia" type="Specific_Interaction"/><entity charOffset="159:184" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.164.e.7" text="changes in renal function" type="Specific_Interaction"/><entity charOffset="196:215" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.164.e.9" text="acute renal failure" type="Specific_Interaction"><Normalization><mmtx cui="C0022660" phraseText="acute renal failure" preferredWord="Kidney Failure, Acute" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.164.ddi.1"><interaction trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.164.e.3"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.142" text="Nitritoid reactions (symptoms include facial flushing, nausea, vomiting, and hypotension) have been reported rarely in patients on therapy with injectable gold (sodium aurothiomalate) and concomitant ACE inhibitor therapy including uniretic."><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.142.e.12"/></ellipsisSentence><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.143" text="Alcohol, Barbiturates, or Narcotics"/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.144" text="Potentiation of orthostatic hypotension may occur in patients on thiazide diuretic therapy with concomitant use of alcohol, barbiturates, or narcotics."/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.145" text="Antidiabetic Agents"/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.146" text="Use of thiazide diuretics concomitantly with antidiabetic agents (oral agents and insulin) may require dosage adjustment of the antidiabetic agent. "/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.147" text="Moexipril has been used in clinical trials concomitantly with oral hypoglycemic agents and there was no evidence of any clinically important adverse interactions."/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.148" text="Cholestyramine and Colestipol Resins"/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.149" text="Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. "/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.150" text="Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85% and 43%, respectively."/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.151" text="Corticosteroids, ACTH"/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.152" text="Use of thiazide diuretics concomitantly with corticosteroids or ACTH may intensify electrolyte depletion, particularly hypokalemia."/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.153" text="Pressor Amines"/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.154" text="Thiazide diuretics may decrease arterial responsiveness to pressor amines"/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.155" text="(e.g. norepinephrine), but not enough to preclude effectiveness of the pressor agent for therapeutic use."/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.156" text="Skeletal Muscle Relaxants, Nondepolarizing"/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.157" text="Thiazide diuretics may increase the responsiveness to tubocurarine."/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.158" text="Non-steroidal Anti-Inflammatory Agents including Selective Cyclooxygenase-2 Inhibitors (COX-2 Inhibitors)"/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.159" text="In patients who are elderly, volume-depleted (including those on diuretic therapy), or with compromised renal function, co-administration of NSAIDS, including selective COX-2 inhibitors, with ACE inhibitors, including moexipril, may result in deterioration of renal function, including possible acute renal failure. "/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.160" text="These effects are usually reversible. "/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.161" text="Monitor renal function periodically in patients receiving moexipril and NSAID therapy."/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.162" text="The antihypertensive effect of ACE inhibitors and hydrochlorothiazide, as well as the diuretic and natriuretic effects of hydrochlorothiazide, may be attenuated by NSAIDS."/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.163" text="Dual Blockade of the Renin-Angiotensin System (RAS)"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.164.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.164.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.164.e.1"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.164.ddi.2"><interaction trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.164.e.5"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.142" text="Nitritoid reactions (symptoms include facial flushing, nausea, vomiting, and hypotension) have been reported rarely in patients on therapy with injectable gold (sodium aurothiomalate) and concomitant ACE inhibitor therapy including uniretic."><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.142.e.12"/></ellipsisSentence><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.143" text="Alcohol, Barbiturates, or Narcotics"/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.144" text="Potentiation of orthostatic hypotension may occur in patients on thiazide diuretic therapy with concomitant use of alcohol, barbiturates, or narcotics."/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.145" text="Antidiabetic Agents"/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.146" text="Use of thiazide diuretics concomitantly with antidiabetic agents (oral agents and insulin) may require dosage adjustment of the antidiabetic agent. "/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.147" text="Moexipril has been used in clinical trials concomitantly with oral hypoglycemic agents and there was no evidence of any clinically important adverse interactions."/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.148" text="Cholestyramine and Colestipol Resins"/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.149" text="Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. "/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.150" text="Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85% and 43%, respectively."/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.151" text="Corticosteroids, ACTH"/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.152" text="Use of thiazide diuretics concomitantly with corticosteroids or ACTH may intensify electrolyte depletion, particularly hypokalemia."/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.153" text="Pressor Amines"/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.154" text="Thiazide diuretics may decrease arterial responsiveness to pressor amines"/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.155" text="(e.g. norepinephrine), but not enough to preclude effectiveness of the pressor agent for therapeutic use."/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.156" text="Skeletal Muscle Relaxants, Nondepolarizing"/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.157" text="Thiazide diuretics may increase the responsiveness to tubocurarine."/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.158" text="Non-steroidal Anti-Inflammatory Agents including Selective Cyclooxygenase-2 Inhibitors (COX-2 Inhibitors)"/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.159" text="In patients who are elderly, volume-depleted (including those on diuretic therapy), or with compromised renal function, co-administration of NSAIDS, including selective COX-2 inhibitors, with ACE inhibitors, including moexipril, may result in deterioration of renal function, including possible acute renal failure. "/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.160" text="These effects are usually reversible. "/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.161" text="Monitor renal function periodically in patients receiving moexipril and NSAID therapy."/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.162" text="The antihypertensive effect of ACE inhibitors and hydrochlorothiazide, as well as the diuretic and natriuretic effects of hydrochlorothiazide, may be attenuated by NSAIDS."/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.163" text="Dual Blockade of the Renin-Angiotensin System (RAS)"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.164.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.164.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.164.e.1"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.164.ddi.3"><interaction trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.164.e.7"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.142" text="Nitritoid reactions (symptoms include facial flushing, nausea, vomiting, and hypotension) have been reported rarely in patients on therapy with injectable gold (sodium aurothiomalate) and concomitant ACE inhibitor therapy including uniretic."><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.142.e.12"/></ellipsisSentence><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.143" text="Alcohol, Barbiturates, or Narcotics"/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.144" text="Potentiation of orthostatic hypotension may occur in patients on thiazide diuretic therapy with concomitant use of alcohol, barbiturates, or narcotics."/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.145" text="Antidiabetic Agents"/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.146" text="Use of thiazide diuretics concomitantly with antidiabetic agents (oral agents and insulin) may require dosage adjustment of the antidiabetic agent. "/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.147" text="Moexipril has been used in clinical trials concomitantly with oral hypoglycemic agents and there was no evidence of any clinically important adverse interactions."/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.148" text="Cholestyramine and Colestipol Resins"/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.149" text="Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. "/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.150" text="Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85% and 43%, respectively."/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.151" text="Corticosteroids, ACTH"/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.152" text="Use of thiazide diuretics concomitantly with corticosteroids or ACTH may intensify electrolyte depletion, particularly hypokalemia."/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.153" text="Pressor Amines"/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.154" text="Thiazide diuretics may decrease arterial responsiveness to pressor amines"/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.155" text="(e.g. norepinephrine), but not enough to preclude effectiveness of the pressor agent for therapeutic use."/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.156" text="Skeletal Muscle Relaxants, Nondepolarizing"/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.157" text="Thiazide diuretics may increase the responsiveness to tubocurarine."/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.158" text="Non-steroidal Anti-Inflammatory Agents including Selective Cyclooxygenase-2 Inhibitors (COX-2 Inhibitors)"/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.159" text="In patients who are elderly, volume-depleted (including those on diuretic therapy), or with compromised renal function, co-administration of NSAIDS, including selective COX-2 inhibitors, with ACE inhibitors, including moexipril, may result in deterioration of renal function, including possible acute renal failure. "/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.160" text="These effects are usually reversible. "/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.161" text="Monitor renal function periodically in patients receiving moexipril and NSAID therapy."/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.162" text="The antihypertensive effect of ACE inhibitors and hydrochlorothiazide, as well as the diuretic and natriuretic effects of hydrochlorothiazide, may be attenuated by NSAIDS."/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.163" text="Dual Blockade of the Renin-Angiotensin System (RAS)"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.164.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.164.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.164.e.1"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.164.ddi.4"><interaction trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.164.e.9"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.142" text="Nitritoid reactions (symptoms include facial flushing, nausea, vomiting, and hypotension) have been reported rarely in patients on therapy with injectable gold (sodium aurothiomalate) and concomitant ACE inhibitor therapy including uniretic."><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.142.e.12"/></ellipsisSentence><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.143" text="Alcohol, Barbiturates, or Narcotics"/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.144" text="Potentiation of orthostatic hypotension may occur in patients on thiazide diuretic therapy with concomitant use of alcohol, barbiturates, or narcotics."/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.145" text="Antidiabetic Agents"/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.146" text="Use of thiazide diuretics concomitantly with antidiabetic agents (oral agents and insulin) may require dosage adjustment of the antidiabetic agent. "/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.147" text="Moexipril has been used in clinical trials concomitantly with oral hypoglycemic agents and there was no evidence of any clinically important adverse interactions."/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.148" text="Cholestyramine and Colestipol Resins"/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.149" text="Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. "/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.150" text="Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85% and 43%, respectively."/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.151" text="Corticosteroids, ACTH"/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.152" text="Use of thiazide diuretics concomitantly with corticosteroids or ACTH may intensify electrolyte depletion, particularly hypokalemia."/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.153" text="Pressor Amines"/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.154" text="Thiazide diuretics may decrease arterial responsiveness to pressor amines"/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.155" text="(e.g. norepinephrine), but not enough to preclude effectiveness of the pressor agent for therapeutic use."/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.156" text="Skeletal Muscle Relaxants, Nondepolarizing"/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.157" text="Thiazide diuretics may increase the responsiveness to tubocurarine."/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.158" text="Non-steroidal Anti-Inflammatory Agents including Selective Cyclooxygenase-2 Inhibitors (COX-2 Inhibitors)"/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.159" text="In patients who are elderly, volume-depleted (including those on diuretic therapy), or with compromised renal function, co-administration of NSAIDS, including selective COX-2 inhibitors, with ACE inhibitors, including moexipril, may result in deterioration of renal function, including possible acute renal failure. "/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.160" text="These effects are usually reversible. "/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.161" text="Monitor renal function periodically in patients receiving moexipril and NSAID therapy."/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.162" text="The antihypertensive effect of ACE inhibitors and hydrochlorothiazide, as well as the diuretic and natriuretic effects of hydrochlorothiazide, may be attenuated by NSAIDS."/><middleSentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.163" text="Dual Blockade of the Renin-Angiotensin System (RAS)"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.164.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.164.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.164.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.164.e.0" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.164.e.2"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.164.e.1" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.164.e.2"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.164.e.0" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.164.e.1"/><pair ddi="true" e1="labelDrug" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.164.e.2"/><pair ddi="true" e1="labelDrug" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.164.e.0"/><pair ddi="true" e1="labelDrug" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.164.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.165" lineNumber="179" text="Closely monitor blood pressure, renal function and electrolytes in patients on uniretic and other agents that affect the RAS." type="regular"><entity charOffset="8:15" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.165.e.0" text="monitor" type="Caution_Interaction"/><entity charOffset="79:87" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.165.e.2" text="uniretic" type="Drug"><Normalization><mmtx cui="C0724120" phraseText="on uniretic" preferredWord="Uniretic" semType="phsu, orch"/><RxNorm RxCui="220670"/></Normalization></entity><entity charOffset="98:124" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.165.e.3" text="agents that affect the RAS" type="Drug_Class"><Normalization><mmtx cui="C1254351" phraseText="other agents" preferredWord="Pharmacologic Substance" semType="phsu"/><RxNorm RxCui="126263"/></Normalization></entity><drugInteraction id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.165.ddi.1"><interaction trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.165.e.0"><relations><relation type="hasObject"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.165.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.165.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.165.e.2" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.165.e.3" trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.165.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.166" lineNumber="181" text="Do not co-administer aliskiren with uniretic in patients with diabetes. " type="regular"><entity charOffset="0:20" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.166.e.0" text="Do not co-administer" type="Caution_Interaction"/><entity charOffset="21:30" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.166.e.2" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="aliskiren with uniretic" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="36:44" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.166.e.3" text="uniretic" type="Drug"><Normalization><mmtx cui="C0724120" phraseText="aliskiren with uniretic" preferredWord="Uniretic" semType="phsu, orch"/><RxNorm RxCui="220670"/></Normalization></entity><entity charOffset="62:70" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.166.e.4" text="diabetes" type="SPAN"><Normalization><mmtx cui="C0011847" phraseText="with diabetes." preferredWord="Diabetes" semType="dsyn"/><mmtx cui="C0011849" phraseText="with diabetes." preferredWord="Diabetes Mellitus" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.166.ddi.1"><interaction trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.166.e.0"><relations><relation type="hasContext"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.166.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.166.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.166.e.3"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.166.e.4" ddi="true" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.166.e.2" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.166.e.3" trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.166.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.167" lineNumber="181" text="Avoid use of aliskiren with uniretic in patients with renal impairment (GFR &lt;60 mL/min)." type="regular"><entity charOffset="54:70" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.167.e.0" text="renal impairment" type="SPAN"><Normalization><mmtx cui="C0035078" phraseText="with renal impairment" preferredWord="Kidney Failure" semType="dsyn"/><mmtx cui="C0341697" phraseText="with renal impairment" preferredWord="Renal impairment" semType="dsyn"/></Normalization></entity><entity charOffset="0:9" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.167.e.1" text="Avoid use" type="Caution_Interaction"/><entity charOffset="13:22" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.167.e.3" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="use of aliskiren" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="28:36" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.167.e.4" text="uniretic" type="Drug"><Normalization><mmtx cui="C0724120" phraseText="with uniretic" preferredWord="Uniretic" semType="phsu, orch"/><RxNorm RxCui="220670"/></Normalization></entity><drugInteraction id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.167.ddi.1"><interaction trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.167.e.1"><relations><relation type="hasObject"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.167.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.167.e.3"/></relation><relation type="hasContext"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.167.e.0"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.167.e.0" ddi="true" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.167.e.3" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.167.e.4" trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.167.e.1" type="Caution_Interaction"/></sentence><sentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.169" text="No clinically important pharmacokinetic interactions occurred when moexipril was administered concomitantly with digoxin or cimetidine." type="negative"><entity charOffset="113:120" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.169.e.0" text="digoxin" type="Biomedical_Entity"><Normalization><mmtx cui="C0012265" phraseText="concomitantly with digoxin" preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><entity charOffset="67:76" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.169.e.1" text="moexipril" type="Biomedical_Entity"><Normalization><mmtx cui="C0066685" phraseText="moexipril" preferredWord="moexipril" semType="phsu, orch"/><RxNorm RxCui="236066"/></Normalization></entity><entity charOffset="124:134" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.169.e.2" text="cimetidine" type="Biomedical_Entity"><Normalization><mmtx cui="C0008783" phraseText="cimetidine." preferredWord="Cimetidine" semType="phsu, orch"/><RxNorm RxCui="2541"/></Normalization></entity><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.169.e.1" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.169.e.0"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.169.e.0" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.169.e.2"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.169.e.1" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.169.e.2"/></sentence><sentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.170" text="Moexipril has been used in clinical trials concomitantly with calcium-channel-blocking agents, diuretics, H2 blockers, digoxin, and cholesterol-lowering agents. " type="negative"><entity charOffset="0:9" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.170.e.0" text="moexipril" type="Biomedical_Entity"><Normalization><mmtx cui="C0066685" phraseText="Moexipril" preferredWord="moexipril" semType="phsu, orch"/><RxNorm RxCui="236066"/></Normalization></entity><entity charOffset="106:117" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.170.e.1" text="h2 blockers" type="Biomedical_Entity"><Normalization><mmtx cui="C0019593" phraseText="H2 blockers," preferredWord="Histamine H2 Antagonists" semType="phsu"/><RxNorm RxCui="34748"/></Normalization></entity><entity charOffset="119:126" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.170.e.2" text="digoxin" type="Biomedical_Entity"><Normalization><mmtx cui="C0012265" phraseText="digoxin," preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><entity charOffset="95:104" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.170.e.3" text="diuretics" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="diuretics," preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="62:93" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.170.e.4" text="calcium-channel-blocking agents" type="Biomedical_Entity"><Normalization><mmtx cui="C0006684" phraseText="with calcium-channel-blocking agents," preferredWord="Calcium Channel Blockers" semType="phsu"/><RxNorm RxCui="1899"/></Normalization></entity><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.170.e.0" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.170.e.1"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.170.e.0" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.170.e.2"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.170.e.0" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.170.e.3"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.170.e.0" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.170.e.4"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.170.e.1" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.170.e.2"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.170.e.3" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.170.e.1"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.170.e.4" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.170.e.1"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.170.e.3" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.170.e.2"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.170.e.4" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.170.e.2"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.170.e.4" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.170.e.3"/></sentence><sentence biomedicalEntities="2" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.172" lineNumber="187" text="In general, ACE inhibitors have less than additive effects with beta-adrenergic blockers, presumably because both work by inhibiting the renin-angiotensin system." type="regular"><entity charOffset="12:26" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.172.e.0" text="ACE inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="In general, ACE inhibitors" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="64:88" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.172.e.1" text="beta-adrenergic blockers" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="with beta-adrenergic blockers," preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="9162"/></Normalization></entity><entity charOffset="32:58" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.172.e.2" text="less than additive effects" type="Specific_Interaction"/><drugInteraction id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.172.ddi.1"><interaction trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.172.e.2"><relations><relation type="hasObject"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.172.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.172.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.172.e.0" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.172.e.1" trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.172.e.2" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.173" lineNumber="189" text="Coadministration of propantheline or guanabenz increased the absorption of hydrochlorothiazide." type="regular"><entity charOffset="20:33" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.173.e.0" text="propantheline" type="Drug"><Normalization><mmtx cui="C0033447" phraseText="Coadministration of propantheline" preferredWord="Propantheline" semType="phsu, orch"/><RxNorm RxCui="8761"/></Normalization></entity><entity charOffset="37:46" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.173.e.1" text="guanabenz" type="Drug"><Normalization><mmtx cui="C0018312" phraseText="guanabenz" preferredWord="Guanabenz" semType="phsu, orch"/><RxNorm RxCui="227225"/></Normalization></entity><entity charOffset="75:94" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.173.e.2" text="hydrochlorothiazide" type="Drug"><Normalization><mmtx cui="C0020261" phraseText="the absorption of hydrochlorothiazide." preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="47:71" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.173.e.3" text="increased the absorption" type="Increase_Interaction"/><drugInteraction id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.173.ddi.1"><interaction trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.173.e.3"><relations><relation type="hasPrecipitant"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.173.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.173.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.173.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.173.e.1" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.173.e.2" trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.173.e.3" type="Increase_Interaction"/><pair ddi="true" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.173.e.0" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.173.e.2" trigger="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.173.e.3" type="Increase_Interaction"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.173.e.0" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.173.e.1"/></sentence><sentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.175" text="Moexipril and hydrochlorothiazide are effective treatments for hypertension. " type="negative"><entity charOffset="0:9" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.175.e.0" text="moexipril" type="Biomedical_Entity"><Normalization><mmtx cui="C0066685" phraseText="Moexipril" preferredWord="moexipril" semType="phsu, orch"/><RxNorm RxCui="236066"/></Normalization></entity><entity charOffset="14:33" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.175.e.1" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.175.e.0" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.175.e.1"/></sentence><sentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.176" text="The recommended dosage range of moexipril is 7.5 to 30 mg daily, administered in a single or two divided doses one hour before meals, while hydrochlorothiazide is effective in a dosage of 12.5 to 50 mg daily." type="negative"><entity charOffset="32:41" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.176.e.0" text="moexipril" type="Biomedical_Entity"><Normalization><mmtx cui="C0066685" phraseText="The recommended dosage range of moexipril" preferredWord="moexipril" semType="phsu, orch"/><RxNorm RxCui="236066"/></Normalization></entity><entity charOffset="140:159" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.176.e.1" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.176.e.0" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.176.e.1"/></sentence><sentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.179" text="Therapy with any combination of moexipril and hydrochlorothiazide will be associated with both sets of dose-independent side effects, but regimens in which moexipril is combined with low doses of hydrochlorothiazide produce minimal effects on serum potassium. " type="negative"><entity charOffset="249:258" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.179.e.0" text="potassium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597277" phraseText="minimal effects on serum potassium." preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="32:41" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.179.e.1" text="moexipril" type="Biomedical_Entity"><Normalization><mmtx cui="C0066685" phraseText="Therapy with any combination of moexipril" preferredWord="moexipril" semType="phsu, orch"/><RxNorm RxCui="236066"/></Normalization></entity><entity charOffset="46:65" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.179.e.2" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="196:215" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.179.e.3" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="combined with low doses of hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="156:165" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.179.e.4" text="moexipril" type="Biomedical_Entity"><Normalization><mmtx cui="C0066685" phraseText="regimens in which moexipril" preferredWord="moexipril" semType="phsu, orch"/><RxNorm RxCui="236066"/></Normalization></entity><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.179.e.1" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.179.e.0"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.179.e.2" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.179.e.0"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.179.e.3" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.179.e.0"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.179.e.4" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.179.e.0"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.179.e.1" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.179.e.2"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.179.e.1" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.179.e.3"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.179.e.2" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.179.e.4"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.179.e.4" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.179.e.3"/></sentence><sentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.180" text="In uniretic controlled clinical trials, the average change in serum potassium was near zero in subjects who received 3.75 mg / 6.25 mg or 7.5 mg / 12.5 mg, but subjects who received 15 mg / 12.5 mg or 15 mg / 25 mg experienced a mild decrease in serum potassium, similar to that experienced by subjects who received the same dose of hydrochlorothiazide monotherapy. " type="negative"><entity charOffset="68:77" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.180.e.0" text="potassium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597277" phraseText="the average change in serum potassium" preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="333:352" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.180.e.1" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="the same dose of hydrochlorothiazide monotherapy." preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="3:11" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.180.e.2" text="uniretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0724120" phraseText="In uniretic controlled clinical trials," preferredWord="Uniretic" semType="phsu, orch"/><RxNorm RxCui="220670"/></Normalization></entity><entity charOffset="252:261" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.180.e.3" text="potassium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597277" phraseText="a mild decrease in serum potassium," preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="8588"/></Normalization></entity><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.180.e.0" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.180.e.1"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.180.e.2" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.180.e.0"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.180.e.2" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.180.e.1"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.180.e.3" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.180.e.1"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.180.e.2" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.180.e.3"/></sentence><sentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.183" text="A patient whose blood pressure is not adequately controlled with either moexipril or hydrochlorothiazide monotherapy may be given uniretic 7.5 mg / 12.5 mg, uniretic 15 mg / 12.5 mg or uniretic 15 mg / 25 mg one hour before a meal. " type="negative"><entity charOffset="157:165" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.183.e.0" text="uniretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0724120" phraseText="uniretic 15 mg / 12.5 mg" preferredWord="Uniretic" semType="phsu, orch"/><RxNorm RxCui="220670"/></Normalization></entity><entity charOffset="130:138" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.183.e.1" text="uniretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0724120" phraseText="uniretic 7.5 mg / 12.5 mg," preferredWord="Uniretic" semType="phsu, orch"/><RxNorm RxCui="220670"/></Normalization></entity><entity charOffset="85:104" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.183.e.2" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="hydrochlorothiazide monotherapy" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="72:81" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.183.e.3" text="moexipril" type="Biomedical_Entity"><Normalization><mmtx cui="C0066685" phraseText="controlled with either moexipril" preferredWord="moexipril" semType="phsu, orch"/><RxNorm RxCui="236066"/></Normalization></entity><entity charOffset="185:193" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.183.e.4" text="uniretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0724120" phraseText="uniretic 15 mg / 25 mg one hour before a meal." preferredWord="Uniretic" semType="phsu, orch"/><RxNorm RxCui="220670"/></Normalization></entity><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.183.e.2" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.183.e.0"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.183.e.3" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.183.e.0"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.183.e.2" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.183.e.1"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.183.e.3" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.183.e.1"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.183.e.3" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.183.e.2"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.183.e.2" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.183.e.4"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.183.e.3" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.183.e.4"/></sentence><sentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.184" text="Further increases of moexipril, hydrochlorothiazide or both depend on clinical response. " type="negative"><entity charOffset="32:51" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.184.e.0" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="21:30" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.184.e.1" text="moexipril" type="Biomedical_Entity"><Normalization><mmtx cui="C0066685" phraseText="Further increases of moexipril," preferredWord="moexipril" semType="phsu, orch"/><RxNorm RxCui="236066"/></Normalization></entity><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.184.e.1" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.184.e.0"/></sentence><sentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.187" text="Patients whose blood pressures are adequately controlled with 25 mg of hydrochlorothiazide daily, but who experience significant potassium loss with this regimen, may achieve blood pressure control without electrolyte disturbance if they are switched to moexipril 3.75 mg/hydrochlorothiazide 6.25 mg (one-half of the uniretic 7.5 mg / 12.5 tablet). " type="negative"><entity charOffset="62:90" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.187.e.0" text="25 mg hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0986526" phraseText="controlled with 25 mg of hydrochlorothiazide daily," preferredWord="Hydrochlorothiazide 25 MG" semType="clnd"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="206:217" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.187.e.1" text="electrolyte" type="Biomedical_Entity"><Normalization><mmtx cui="C0013832" phraseText="blood pressure control without electrolyte disturbance" preferredWord="Electrolytes" semType="inch, phsu"/><RxNorm RxCui="3793"/></Normalization></entity><entity charOffset="254:291" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.187.e.2" text="moexipril hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0717828" phraseText="to moexipril 3.75 mg/hydrochlorothiazide 6.25 mg (one-half" preferredWord="Hydrochlorothiazide / moexipril" semType="phsu, orch"/><RxNorm RxCui="236066"/></Normalization></entity><entity charOffset="317:325" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.187.e.3" text="uniretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0724120" phraseText="of the uniretic 7.5 mg / 12.5 tablet" preferredWord="Uniretic" semType="phsu, orch"/><RxNorm RxCui="220670"/></Normalization></entity><entity charOffset="129:138" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.187.e.4" text="potassium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597277" phraseText="significant potassium loss with this regimen," preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="8588"/></Normalization></entity><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.187.e.0" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.187.e.1"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.187.e.0" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.187.e.2"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.187.e.0" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.187.e.3"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.187.e.0" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.187.e.4"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.187.e.1" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.187.e.2"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.187.e.1" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.187.e.3"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.187.e.4" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.187.e.1"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.187.e.2" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.187.e.3"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.187.e.4" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.187.e.2"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.187.e.4" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.187.e.3"/></sentence><sentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.188" text="For patients who experience an excessive reduction in blood pressure with uniretic 7.5 mg / 12.5 mg, the physician may consider prescribing moexipril 3.75 mg/hydrochlorothiazide 6.25 mg." type="negative"><entity charOffset="74:82" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.188.e.0" text="uniretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0724120" phraseText="with uniretic 7.5 mg / 12.5 mg," preferredWord="Uniretic" semType="phsu, orch"/><RxNorm RxCui="220670"/></Normalization></entity><entity charOffset="140:177" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.188.e.1" text="moexipril hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0717828" phraseText="moexipril 3.75 mg/hydrochlorothiazide 6.25 mg." preferredWord="Hydrochlorothiazide / moexipril" semType="phsu, orch"/><RxNorm RxCui="236066"/></Normalization></entity><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.188.e.0" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.188.e.1"/></sentence><sentence id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.193" text="In patients with more severe renal impairment, loop diuretics are preferred to thiazides, so uniretic is not recommended (see PRECAUTIONS, General)." type="negative"><entity charOffset="79:88" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.193.e.0" text="thiazides" type="Biomedical_Entity"><Normalization><mmtx cui="C0541746" phraseText="preferred to thiazides," preferredWord="Thiazides" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><entity charOffset="47:61" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.193.e.1" text="loop diuretics" type="Biomedical_Entity"><Normalization><mmtx cui="C0354100" phraseText="loop diuretics" preferredWord="Loop Diuretics" semType="phsu"/><RxNorm RxCui="104215"/></Normalization></entity><entity charOffset="93:101" id="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.193.e.2" text="uniretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0724120" phraseText="uniretic" preferredWord="Uniretic" semType="phsu, orch"/><RxNorm RxCui="220670"/></Normalization></entity><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.193.e.1" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.193.e.0"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.193.e.0" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.193.e.2"/><pair ddi="false" e1="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.193.e.1" e2="Dailymed.333ee96f-66b6-415f-9ea3-0710b3eee1dd.s.193.e.2"/></sentence><positiveExamples number="40"/><negativeExamples number="145"/></document>